On State-of-art of Treatment of Very-early Stage Hepatocellular Carcinoma
10.3969/j.issn.1009-6604.2015.08.021
- VernacularTitle:极早期肝癌的治疗现状
- Author:
Yun XU
;
Qiang SHEN
;
Guojun QIAN
- Publication Type:Journal Article
- Keywords:
Hepatocellular carcinoma;
Liver transplantation;
Percutaneous ablation;
Transarterial chemoembolization
- From:
Chinese Journal of Minimally Invasive Surgery
2015;(8):739-743
- CountryChina
- Language:Chinese
-
Abstract:
[Summary] In the treatment of very-early stage hepatocellular carcinoma ( HCC) , several therapies have their own strengths . Liver transplantation, surgical resection, and percutaneous ablation are the most effective procedures for very-early stage HCC.Liver transplantation is difficult to carry out due to lack of donors .Surgical resection and percutaneous ablation are the most commonly used methods with ideal effects .Compared with surgical resection , percutaneous ablation has its obvious advantages in patients with small HCC and senile patients , but the recurrence rate is relatively high .When the above mentioned three methods are not feasible , transarterial chemoembolization is a remedial treatment .Combined use of local therapy is superior to topical therapy alone and suitable for patients with unresectable lesions .Theobserving therapystill needs more clinical studies to confirm its safety and effectiveness .
